Strategy analysis
| Strategy recommendation | Examples of why drug use should have been considered |
|---|---|
| (1) Life-course approach | Substance use often precedes and can exacerbate existing mental health problems (Hartz et al., 2014). But there is still more to understand about the relationship between drugs and mental health |
| (2) Patient and public involvement | Involving service users who have experience of dual diagnosis would improve our understanding of their needs and the support they would benefit from (Wells et al., 2008). This remains an ambition rather than a reality |
| (3) Mental and physical health | Drug use impacts on physical and mental health, capturing this in research outcomes measurement is critical (Robson et al., 2008) |
| (4) Co-ordination and infrastructure | Dual diagnosis does not fit the aim or scope of many major research funding bodies despite the potential for applied research |
| (5) Data, informatics and virtual populations | Improved data reporting at a population level must include drug use given the incidence and prevalence of dual diagnosis (Lai et al., 2015) |
| (6) Flexible funding | Collaboration between researchers in mental health and addiction is critical but structurally impeded, see point 4 (Sellman, 2010) |
| (7) Emerging interventions and alternative settings | Investigating dual diagnosis beyond the treatment setting would provide intelligence that could inform prevention strategies and interventions (Gore et al., 2015) |
| (8) Industry engagement | Insufficient information is available about the way medication benefits or presents risks to people with a dual diagnosis. Drug use excludes potential participants from trials in mental health and vice versa (Hamilton and Pringle, 2013) |
| (9) Regulation, ethics and governance | Research ethics committees should also have people who understand the association between drugs and mental health |
| (10) Capacity building | Multi-disciplinary research must include professionals and service users from the field of addiction if the ambition of applied research is to be realised (Fonseca et al., 2012) |
| Strategy recommendation | Examples of why drug use should have been considered |
|---|---|
| (1) Life-course approach | Substance use often precedes and can exacerbate existing mental health problems ( |
| (2) Patient and public involvement | Involving service users who have experience of dual diagnosis would improve our understanding of their needs and the support they would benefit from ( |
| (3) Mental and physical health | Drug use impacts on physical and mental health, capturing this in research outcomes measurement is critical ( |
| (4) Co-ordination and infrastructure | Dual diagnosis does not fit the aim or scope of many major research funding bodies despite the potential for applied research |
| (5) Data, informatics and virtual populations | Improved data reporting at a population level must include drug use given the incidence and prevalence of dual diagnosis ( |
| (6) Flexible funding | Collaboration between researchers in mental health and addiction is critical but structurally impeded, see point 4 ( |
| (7) Emerging interventions and alternative settings | Investigating dual diagnosis beyond the treatment setting would provide intelligence that could inform prevention strategies and interventions ( |
| (8) Industry engagement | Insufficient information is available about the way medication benefits or presents risks to people with a dual diagnosis. Drug use excludes potential participants from trials in mental health and vice versa ( |
| (9) Regulation, ethics and governance | Research ethics committees should also have people who understand the association between drugs and mental health |
| (10) Capacity building | Multi-disciplinary research must include professionals and service users from the field of addiction if the ambition of applied research is to be realised ( |
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.